Related Experiment Video
Updated: Aug 11, 2026

05:56
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
Prevention of myopia progression with 0.05% atropine solution
Jong-Jer Lee1, Po-Chiung Fang, I-Hui Yang
1Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, Republic of China.
Summary
Low-dose atropine eye drops effectively slow myopia progression in children. This study found 0.05% atropine significantly reduced the rate of worsening nearsightedness in school-aged participants over one year.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Myopia Control
Background:
- Myopia is a growing public health concern in school-aged children.
- Effective interventions are needed to slow myopia progression and prevent high myopia.
- Topical atropine has shown promise in myopia management.
Purpose of the Study:
- To evaluate the efficacy of 0.05% atropine solution in controlling myopia progression.
- To compare myopia progression rates in children treated with 0.05% atropine versus a control group.
Main Methods:
- A retrospective, case-control study involving 57 myopic children (6-12 years old).
- One group received 0.05% atropine eyedrops nightly; the control group received no treatment.
- Refractive status changes were monitored over at least one year.
Main Results:
- Children treated with 0.05% atropine showed significantly slower myopia progression (-0.28 D/year) compared to controls (-0.75 D/year).
- The atropine group had a substantially lower rate of uncontrolled myopia progression (16.7% vs. 77.8%).
- The differences in progression rates were statistically significant (P < 0.001).
Conclusions:
- Topical 0.05% atropine is an effective treatment for controlling myopia progression in most school-aged children.
- Regular nightly instillation of low-dose atropine can manage myopia over a one-year period.
- This intervention offers a viable option for reducing the progression of nearsightedness in pediatric populations.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Focusing of Light in the Eye
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
